Henry Schein
HSIC
Delayed Nasdaq - 11/17 07:18:16 pm
69.11USD
-0.58%
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Medical Equipment Wholesale
Distributes healthcare products and services

Henry Schein, Inc. engages in the provision of providing health care products and services to medical, dental, and veterinary office-based practitioners.

It operates through the following business segments: Healthcare Distribution, and Technology & Value-Added Services.

The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services.

The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Number of employees : 21 000 persons.
Sales per Businesses
20152016
USD
(in Million)
%USD
(in Million)
%
Health Care Distribution10,27196.6%11,14696.3%
Technology & Value-Added Services358.773.4%425.613.7%
Sales per Regions
20152016
USD
(in Million)
%USD
(in Million)
%
United States6,79964%7,53765.1%
Other3,83136%4,03534.9%
Shareholders
- The Vanguard Group, Inc.10.1%
- Fidelity Management & Research Co.8.66%
- T. Rowe Price Associates, Inc.5.63%
- BlackRock Fund Advisors5.38%
- SSgA Funds Management, Inc.4.56%
- Alecta Pension Insurance Mutual3.36%
Managers
- Chairman & Chief Executive Officer :
    Stanley Bergman
- President & Director :
    James Breslawski
- Chief Financial Officer, Director & Executive VP :
    Steven Paladino
- Chief Technology Officer & Senior Vice President :
    James Harding
- Lead Independent Director :
    Philip Laskawy
- Independent Director :
    Barry Alperin
- Director, Chief Administrative Officer & EVP :
    Gerald Benjamin
- Independent Director :
    Donald Kabat
- Director, Chief Strategic Officer & Executive VP :
    Mark Mlotek
- Independent Director :
    Paul Brons
Company contact information
135 road Duryea
US-NY 11747 Melville, New York
États-Unis (les)

Phone : +1 631 843 5500
Fax : +1
Internet : http://www.henryschein.com
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 500
Stock Exchange Codes
- ISIN Code :  US8064071025
- Bloomberg Code :  HSIC:US
- Reuters Code :  HSIC.O
Overall rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision